News
Spanish company Aortyx has secured €13.8m ($15.8m) in a Series A financing round to further develop its bioresorbable patch, ...
GE HealthCare has released software combining its own imaging functionalities with tools enabled by a platform developed by ...
Wandercraft has raised $75m in a Series D funding round to introduce the self-balancing personal exoskeleton, Eve, to market ...
Amid ongoing trade policy debates, leaders from the medtech industry convened on Capitol Hill alongside the Advanced Medical ...
Cognito has reported outcomes from a post hoc analysis of its OVERTURE trial, indicating that the Spectris AD can slow the ...
The health secretary addressed NHS employees a day after the £29bn NHS funding was announced. A £29bn investment into the ...
Sofinnova Partners has partnered with NVIDIA in a move intended to equip its life sciences portfolio companies with faster ...
The US FDA has granted 510(k) clearance to Neurent Medical's NEUROMARK System for the treatment of individuals with chronic ...
Somnee announced that it has secured $10m in a seed extension round to advance its AI-powered neurotech sleep wearables.
Mainz Biomed has started the feasibility phase of the PancAlert project to develop a pancreatic cancer screening test.
Johnson & Johnson MedTech has introduced the ETHICON 4000 Stapler, a surgical device for managing tissue complexities.
The Florida Cancer Specialists & Research Institute (FCS) has introduced a liquid biopsy test to identify circulating cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results